Application 062973
- Type
- ANDA
- Sponsor
- APOTHECON
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CEPHALEXIN | CEPHALEXIN | CAPSULE;ORAL | EQ 250MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A062973-001 | CEPHALEXIN | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | d4dbc9d85df4… | ||
| 2026-10-15 13:18:30 | 2026-09 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | c2088c7a36db… | ||
| 2026-09-14 22:38:34 | 2026-08 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A062973-001 | CEPHALEXIN | EQ 250MG BASE | CAPSULE / ORAL | 1988-11-08 | 3bdfa0b2c4d7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cephalexin | CEPHALEXIN | REMEDYREPACK INC. | 2506895d-f3e0-4be9-95cb-7a6fd44de46d | 2026-11-06 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | REMEDYREPACK INC. | 9fc5cfb0-7ba0-4669-b79c-270b6a9ff573 | 2026-10-29 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | 681c235f-6dee-1401-e053-2991aa0addc0 | 2026-10-28 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | REMEDYREPACK INC. | c0ca008e-0e28-412e-a58f-70f63817713b | 2026-10-23 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | 7cbdfa7f-2ea0-48e1-b506-59f58e5685a6 | 2026-10-19 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | A-S Medication Solutions | 73920373-b45d-45d6-b183-d962467dde36 | 2026-10-19 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | Ascend Laboratories, LLC | 36882c6d-7b6f-41e3-8c54-e3b0073b8c07 | 2026-10-16 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | Northwind Health Company, LLC | 4ecf9314-76e2-c270-e063-6294a90ad8db | 2026-10-16 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | REMEDYREPACK INC. | 8499aa5a-49b1-4555-bd27-6177d92b261d | 2026-10-15 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | REMEDYREPACK INC. | b3bb8222-161e-4d9c-8e08-7e22ad65bf72 | 2026-10-13 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | REMEDYREPACK INC. | b73593ce-0b1f-4371-bae1-140742de3b42 | 2026-10-12 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | Ascend Laboratories, LLC | bb28751c-bd1b-4e7f-8271-a14c1b4314e3 | 2026-10-12 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | Aurobindo Pharma Limited | f957ea27-2906-40c7-ac03-eb2f742473a0 | 2026-09-15 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | Aurobindo Pharma Limited | 8e28f049-6110-4473-830f-c494191a7197 | 2026-09-15 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | PD-Rx Pharmaceuticals, Inc. | e54df878-c235-4aa3-af33-fe5287c73138 | 2026-09-14 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | PD-Rx Pharmaceuticals, Inc. | 1716ea1e-40a9-4a23-870b-3c7e3d070095 | 2026-09-14 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | NuCare Pharmaceuticals,Inc. | 6c543819-ab98-1dcd-e053-2991aa0a109d | 2026-09-14 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | Teva Pharmaceuticals USA, Inc. | 5858b90a-a80d-40b4-9275-b89e9121ea42 | 2026-09-02 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | Lupin Pharmaceuticals, Inc. | 1d3e6d33-5dc2-498e-8efa-e3c4fca15dff | 2026-08-24 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
| Cephalexin | CEPHALEXIN | HAWAII REPACK, INC. | d54abc0a-3c8f-4f02-bd55-406f0c5b925a | 2026-08-18 | Warnings, Adverse reactions | Cephalexin CEPHALEXIN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.